This study will enroll kidney transplant patients to evaluate the TruGraf and TRAC blood tests which can help monitor for transplant kidney rejection. Participants will have blood draws every 3 months for 2 years and the study team will collect information on long term health outcomes.

This study will monitor for kidney rejection using the Allosure and AlloMap test. Subjects will be followed for 3 years post transplant.